North America Primary Angle Closure Glaucoma Market Analysis

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Pharmaceutical North America Primary Angle Closure Glaucoma Market Market Analysis
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Primary Angle Closure Glaucoma Market Analysis

  • Pharmaceutical
  • Published Report
  • Aug 2021
  • North America
  • 350 Pages
  • No of Tables: 35
  • No of Figures: 36
Buy Now Buy Now

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET end user coverage GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Epidemiology
  5. Regulatory Framework
  6. Pipeline analysis
  7. market overview
    1. drivers
      1. INCREASING PREVALENCE OF ANGLE-CLOSURE GLAUCOMA
      2. INCREASING WOMEN POPULATION
      3. RISE IN GERIATRIC POPULATION
      4. ADVANCEMENTS IN SURGICAL TREATMENT OF THE DISEASE
      5. INCREASED ECONOMIC BURDEN
    2. RESTRAINTS
      1. HIGH SURGICAL COSTS OF PACG
      2. INADEQUATE REIMBURSEMENT SCENARIO
      3. DELAYED AND MISDIAGNOSIS OF PACG
    3. OPPORTUNITIES
      1. INCREASING GOVERNMENT INITIATIVES TOWARDS GLAUCOMA
      2. RECENT APPROVAL BY GOVERNING BODIES
      3. RAPID TRANSITION FROM PACG MEDICATION TO SURGERIES
    4. CHALLENGES
      1. RISKS ASSOCIATED WITH SURGICAL PROCEDURES
      2. LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
      3. LIMITED ACCESS TO TREATMENT
  8. IMPACT OF COVID-19 ON North america PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS
    5. CONCLUSION
  9. NORTH AMERICA PRIMARY ANGLE CLOSURE GLAUCOMA Market, By DISEASE TYPE
    1. overview
    2. acute angle-closure glaucoma market
    3. chronic angle-closure glaucoma market
  10. North america primary angle-closure glaucoma MARKET, BY TYPE
    1. overview
    2. Diagnosis
      1. primary test
        1. GONIOSCOPY EXAMINATION
        2. SLIT-LAMP EXAMINATION
        3. AUTOMATIC STATIC PERIMETRY
      2. SECONDARY test
        1. ULTRASOUND BIOMICROSCOPY
        2. ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY (OCT)
        3. RETINAL OCT
        4. FUNDOSCOPY
        5. OTHERS
    3. Treatment
      1. Surgical Iridectomy
      2. TRABECULECTOMY
      3. Micro invasive glaucoma technique (MIGS)
      4. goniotomy
      5. Others
  11. North America primary angle-closure glaucoma MARKET, BY end user
    1. overview
    2. HoSpitals
    3. AMbulatory surgical Centers
    4. Specialty Clinics
    5. others
  12. North America Primary Angle-Closure Glaucoma MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. retail sales
    4. Others
  13. North America primary angle-closure glaucoma MARKET, BY Country
    1. NORTH AMERICA
      1. U.S.
      2. CANADA
      3. MEXICO
  14. North America primary angle-closure glaucoma Market: COMPANY landscape
    1. company share analysis: North America
  15. SWOT
  16. company profiles
    1. johnson & johnson vision care, inc. (a subsidiary of johnson & johnson services, inc.)
      1. COMPANY SNAPSHot
      2. Revenue analysis
      3. product Portfolio
      4. RECENT DEVELOPMENTS
    2. bausch & lomb incorporated (a subsidiary of bausch health Companies Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. alcon inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. Zeiss International
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. NOVA EYE MEDICAL LIMITED
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. NIDEK CO., LTD
      1. COMPANY SNAPShot
      2. product Portfolio
      3. RECENT DEVELOPMENTS
    7. allergan (a subsidiary of abbvie inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    8. BVI
      1. COMPANY SNAPSHot
      2. product Portfolio
      3. RECENT DEVELOPMENTS
    9. LIGHTMED
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. Luneau technology usa
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. microsurgical technology
      1. COMPANY SNAPSHot
      2. product Portfolio
      3. RECENT DEVELOPMENTS
    12. new vision
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    13. New World Medical, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. Oertli Instrumente AG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. Reichert, inc. (A business unit of ametek.inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. Sight Sciences, inc.
      1. COMPANY SNAPSHot
      2. product Portfolio
      3. RECENT DEVELOPMENTS
  17. questionnaire
  18. related reports

List of Table

TABLE 1 NORTH AMERICA Primary Angle-Closure Glaucoma Market, Pipeline Analysis

TABLE 2 NUMBER OF OPHTHALMOLOGISTS/MILLION POPULATIONS

TABLE 3 North america Primary angle closure glaucoma market, By disease type, 2019-2028 (USD million)

TABLE 4 North america Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 5 North America Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 6 North america Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 7 North america Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 8 North America Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 9 North America Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 10 North America Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 11 North America PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)

TABLE 12 U.S. PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 13 U.S. Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 14 U.S. Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 15 U.S. Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 16 U.S. Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 17 U.S. Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 18 U.S. Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 19 U.S. Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 20 CANADA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 21 CANADA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 22 CANADA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 23 CANADA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 24 CANADA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 25 CANADA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 26 CANADA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 27 CANADA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 28 MEXICO PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 29 MEXICO Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 30 MEXICO Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 31 MEXICO Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 32 MEXICO Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 33 MEXICO Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 34 MEXICO Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 35 MEXICO Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

List of Figure

FIGURE 1 NORTH America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: segmentation

FIGURE 2 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET : data triangulation

FIGURE 3 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: North America VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: MULTIVARIATE MODELLING

FIGURE 7 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: DBMR MARKET POSITION GRID

FIGURE 9 North America primary angle-closure glaucoma market: MARKET end user coverage GRID

FIGURE 10 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 North america primary angle-closure glaucoma market: SEGMENTATION

FIGURE 12 INCREASING PREVALENCE OF ANGLE-CLOSURE GLAUCOMA and ADVANCEMENT IN SURGICAL TREATMENT OF THE DISEASE are DRIVing THE NORTH AMERICA primary angle-closure glaucoma market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 ACUTE ANGLE-CLOSURE GLAUCOMA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET

FIGURE 15 North America Primary angle closure glaucoma market: By disease type, 2020

FIGURE 16 North america Primary angle closure glaucoma market: By disease type, 2020-2028 (USD Million)

FIGURE 17 North America Primary angle closure glaucoma market: By disease type, CAGR (2020-2028)

FIGURE 18 North america Primary angle closure glaucoma market: By disease type, LIFELINE CURVE

FIGURE 19 North america primary angle-closure glaucoma market: BY TYPE, 2020

FIGURE 20 North america primary angle-closure glaucoma market: BY TYPE 2020-2028 (USD Million)

FIGURE 21 North america primary angle-closure glaucoma market: BY TYPE, CAGR (2021-2028)

FIGURE 22 North america primary angle-closure glaucoma market: BY TYPE, LIFELINE CURVE

FIGURE 23 North America Primary Angle-Closure Glaucoma market: BY end user, 2020

FIGURE 24 North America Primary Angle-Closure Glaucoma market: BY end user, 2020-2028 (USD Million)

FIGURE 25 North America Primary Angle-Closure Glaucoma market: BY end user, CAGR (2021-2028)

FIGURE 26 North America Primary Angle-Closure Glaucoma market: BY end user, LIFELINE CURVE

FIGURE 27 North America Primary Angle-Closure Glaucoma market: BY distribution channel, 2020

FIGURE 28 North America Primary Angle-Closure Glaucoma market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 29 North America Primary Angle-Closure Glaucoma market: BY distribution channel, CAGR (2021-2028)

FIGURE 30 North America Primary Angle-Closure Glaucoma market: BY distribution, LIFELINE CURVE

FIGURE 31 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)

FIGURE 32 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)

FIGURE 33 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)

FIGURE 34 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)

FIGURE 35 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)

FIGURE 36 north america primary angle-closure glaucoma market: company share 2020 (%)

Frequently Asked Questions

The market is segmented based on North America Primary Angle-Closure Glaucoma Market, By Disease Type (Acute Angle-Closure Glaucoma and Chronic Angle-Closure Glaucoma), Type (Diagnosis and Treatment), End User (Hospitals, Ambulatory Surgical Centres, Specialty Clinics and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028. .
The North America Primary Angle Closure Glaucoma Market size was valued at USD 113.24 USD Million in 2020.
The North America Primary Angle Closure Glaucoma Market is projected to grow at a CAGR of 5.7% during the forecast period of 2021 to 2028.

Browse Related Pages

Banner